BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:48 PM
 | 
Oct 25, 2007
 |  BC Extra  |  Clinical News

Eli Lilly suspends prasugrel Phase IIs

LLY was off $3.72 to $52.43 on 22.8 million shares Thursday after reporting late Wednesday that it had suspended enrollment in a pair of Phase II trials of prasugrel ( CS-747)...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >